Beckman Coulter Up for Sale: Report
NEW YORK (
) --
Beckman Coulter
(BEC)
has reportedly decided to put itself on the auction block after receiving a number of indications of interest.
Multiple media outlets were saying late Thursday that the Brea, Calif.-based maker of biomedical testing equipment plans to test the market in the wake of recent overtures from both private equity firms and rival companies.
A
New York Times
report said the company has hired
Goldman Sachs
(GS) - Get Report
to serve as its strategic advisor in the process. The
Wall Street Journal
, citing people familiar with the matter, estimated Beckman Coulter could fetch as much as $5 billion in a sale, and also said Goldman was running the sale, which began a few weeks ago and is expected to take at least a few weeks more. The company's current market capitalization is just under $4 billion
Shares of Beckman Coulter finished on Thursday at $57.09, down 34 cents. Year-to-date, the stock is down about 12.2%, but it's seen a healthy bounce since dipping to a 52-week low of $44.40 on Aug. 4.
At current levels, the forward price-to-earnings multiple on the stock, based on the consensus view for fiscal 2011, is 14X. The average estimate of analysts polled by
Thomson Reuters
is for the company to post a profit of $1.23 a share for the December-ending quarter on revenue of $995.3 million.
--
Written by Michael Baron in New York.
>To contact the writer of this article, click here:
Michael Baron
.
>To submit a news tip, send an email to:
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.